Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Keytruda generated $31.7 billion in sales in 2025, while the second and third spots on the leaderboard were occupied by GLP-1 drugs: Mounjaro with nearly $23 billion and Ozempic with about $20 billion
Abstract Current management of chronic kidney disease (CKD) in type 1 diabetes centres on glycaemic control, reninangiotensin system inhibition and optimisation of risk factors including blood pressure, lipids and body weight
Dr Michael Mrozinski found out the hard way that the unlicensed and largely untested peptide can impact the mind just as much as the body after taking it for six months during his 20s
Coordinated strategies among manufacturers, payers, and regulators are urgently needed to expand production capacity and maintain supply stability
US$ 24.47
US$ 27.79
US$ 26.84
US$ 25.15
US$ 27.62
US$ 27.43
US$ 24.65
US$ 27.02
US$ 25.47
US$ 26.82
US$ 29.70
